An overview of publicly available patient-centered prostate cancer datasets, Translational Andrology and Urology, vol.8, issue.S1, pp.S64-S77, 2019. ,
Gleason grade progression is uncommon, Cancer Res, vol.73, pp.5163-5168, 2013. ,
Cancer statistics, 2019, CA: A Cancer Journal for Clinicians, vol.69, issue.1, pp.7-34, 2019. ,
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin, vol.68, pp.394-424, 2018. ,
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates, European Urology, vol.77, issue.1, pp.38-52, 2020. ,
Genetics and biology of prostate cancer, Genes & Development, vol.32, issue.17-18, pp.1105-1140, 2018. ,
, Committee The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, vol.29, pp.1228-1242, 2005.
A case report of multiple primary prostate tumors with differential drug sensitivity, Nat. Commun, vol.11, 2020. ,
Cancer Progress and Priorities: Prostate Cancer, Cancer Epidemiol. Biomark. Prev, vol.29, pp.267-277, 2020. ,
Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?, Journal of Clinical Oncology, vol.27, issue.21, pp.3459-3464, 2009. ,
Molecular mechanisms involving prostate cancer racial disparity, Am. J. Clin. Exp. Urol, vol.5, pp.34-48, 2017. ,
Integrative genomic profiling of human prostate cancer, Cancer Cell, vol.18, pp.11-22, 2010. ,
, Cancer Genome Atlas Research Network the Molecular Taxonomy of Primary Prostate Cancer, vol.163, pp.1011-1025, 2015.
The mutational landscape of lethal castration-resistant prostate cancer, Nature, vol.487, pp.239-243, 2012. ,
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer, Nat. Genet, vol.44, pp.685-689, 2012. ,
Genomic hallmarks of localized, non-indolent prostate cancer, Nature, vol.541, pp.359-364, 2017. ,
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer, Nat. Med, vol.22, pp.369-378, 2016. ,
Copy number alteration burden predicts prostate cancer relapse, Proc. Natl. Acad. Sci, vol.111, pp.11139-11144, 2014. ,
Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors, Cancer Cell, vol.36, issue.6, pp.674-689.e6, 2019. ,
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer, Nature, vol.448, pp.595-599, 2007. ,
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, vol.310, pp.644-648, 2005. ,
The long tail of oncogenic drivers in prostate cancer, Nat. Genet, vol.50, pp.645-651, 2018. ,
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing, Eur. Urol. Focus, vol.4, pp.707-710, 2018. ,
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity, Clin. Cancer Res, vol.24, pp.5585-5593, 2018. ,
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death, vol.7, 2018. ,
Genomic correlates of clinical outcome in advanced prostate cancer, Proc. Natl. Acad. Sci, vol.116, pp.11428-11436, 2019. ,
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study, Nat. Genet, vol.43, pp.785-791, 2011. ,
A family of human zinc finger proteins that bind methylated DNA and repress transcription, Mol. Cell. Biol, vol.26, pp.169-181, 2006. ,
Structural insights into methylated DNA recognition by the C-terminal zinc fingers of the DNA reader protein ZBTB38, J. Biol. Chem, vol.293, 2018. ,
The C-Terminal Zinc Fingers of ZBTB38 are Novel Selective Readers of DNA Methylation, J. Mol. Biol, vol.430, pp.258-271, 2018. ,
The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile site stability, Cell Rep, vol.7, pp.575-587, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02187826
Stabilization of the methyl-CpG binding protein ZBTB38 by the deubiquitinase USP9X limits the occurrence and toxicity of oxidative stress in human cells, Nucleic Acids Res, vol.46, pp.4392-4404, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02132922
Depletion of ZBTB38 potentiates the effects of DNA demethylating agents in cancer cells via CDKN1C mRNA up-regulation, vol.7, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02132553
CIBZ Regulates Mesodermal and Cardiac Differentiation of by Suppressing T and Mesp1 Expression in Mouse Embryonic Stem Cells, Sci. Rep, vol.6, 2016. ,
CtBP-interacting BTB zinc finger protein (CIBZ) promotes proliferation and G1/S transition in embryonic stem cells via Nanog, J. Biol. Chem, vol.287, pp.12417-12424, 2012. ,
The methyl-CpG-binding protein CIBZ suppresses myogenic differentiation by directly inhibiting myogenin expression, Cell Res, vol.21, pp.1578-1590, 2011. ,
Transcriptome profiling reveals the role of ZBTB38 knock-down in human neuroblastoma ,
The role of ZBTB38 in promoting migration and invasive growth of bladder cancer cells, Oncol. Rep, vol.41, 1980. ,
Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer, Cancers, vol.11, p.1692, 2019. ,
DNA Methylation and Chromatin: Role(s) of Methyl-CpG-Binding Protein ZBTB38, Epigenet, vol.11, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02132547
Oxidative stress in prostate cancer patients: A systematic review of case control studies, Prostate Int, vol.4, pp.71-87, 2016. ,
Oxidative stress in prostate hyperplasia and carcinogenesis, J. Exp. Clin. Cancer Res, vol.35, p.139, 2016. ,
Mitochondrial functions and melatonin: A tour of the reproductive cancers, Cell. Mol. Life Sci, vol.76, pp.837-863, 2019. ,
Regulation of reactive oxygen species generation in cell signaling, Mol. Cells, vol.32, pp.491-509, 2011. ,
Gene expression profiling identifies clinically relevant subtypes of prostate cancer, Proc. Natl. Acad. Sci. USA, vol.101, pp.811-816, 2004. ,
Gene expression analysis of prostate cancers, Mol. Carcinog, vol.33, pp.25-35, 2002. ,
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression, Cancer Cell, vol.8, pp.393-406, 2005. ,
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study, vol.2, pp.1133-1144, 2015. ,
Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer, Clin. Cancer Res, vol.15, pp.5794-5802, 2009. ,
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer, PLoS ONE, vol.5, 2010. ,
Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression, Cancer Res, vol.63, pp.3877-3882, 2003. ,
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of, Cancer. Cell, vol.173, pp.291-304, 2018. ,
Integrative clinical genomics of advanced prostate cancer, vol.161, pp.1215-1228, 2015. ,
Doxorubicin targets multiple players: A new view of an old problem, Pharmacol. Res, vol.127, pp.4-14, 2018. ,
Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells: Role of plasma membrane depolarization, Oncotarget, vol.6, pp.21572-21588, 2015. ,
Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression, Cancer Biol. Ther, vol.1, pp.520-527, 2002. ,
Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells, Am. J. Pathol, vol.181, pp.1836-1846, 2012. ,
Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters, Mol. Cancer Ther, vol.11, pp.1852-1862, 2012. ,
Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c, Cancer Lett, vol.431, pp.1-10, 2018. ,
SPOP mutation leads to genomic instability in prostate cancer, vol.4, p.9207, 2015. ,
Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer, Cancer Res, vol.74, pp.5631-5643, 2014. ,
Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants, Cell Rep, vol.6, pp.657-669, 2014. ,
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression, Dev. Cell, vol.48, pp.329-344, 2019. ,
Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer, Cancer Sci, vol.98, pp.1720-1726, 2007. ,
Oxidative stress induces ADAM9 protein expression in human prostate cancer cells, Cancer Res, vol.66, pp.9519-9526, 2006. ,
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal, issue.6, 2013. ,
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles, Neoplasia, vol.9, pp.166-180, 2007. ,
, NCBI Resource Coordinators Database resources of the National Center for Biotechnology Information, Nucleic Acids Res, vol.46, pp.8-13, 2018.
Profiler: A web server for functional enrichment analysis and conversions of gene lists (2019 update), Nucleic Acids Res, vol.47, pp.191-198, 2019. ,
Molecular signatures database (MSigDB) 3.0, Bioinformatics, vol.27, pp.1739-1740, 2011. ,